View:
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) INCYTE PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 45337C 10 2 --------------------------------------------- (CUSIP Number) The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act. Page 1 of 13 Pages CUSIP No. 45337C 10 2 13G Page 2 of 13 Pages - -------------------------------------------------------------------------------- 1. Names of Reporting Persons Jeffrey J. Collinson S.S. or I.R.S. Identification Nos. of Above Persons ###-##-#### - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization U.S. Citizen - -------------------------------------------------------------------------------- 5. Sole Voting Power 6,005 Number of ----------------------------------------------------- Shares Beneficially 6. Shared Voting Power 418,892 Owned by ----------------------------------------------------- Each Reporting 7. Sole Dispositive Power 6,005 Person ----------------------------------------------------- With 8. Shared Dispositive Power 418,892 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 424,897 - -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row 9 Excludes Certain Shares [ ] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row 9 4.1% - -------------------------------------------------------------------------------- 12. Type of Reporting Person IN - -------------------------------------------------------------------------------- CUSIP No. 45337C 10 2 13G Page 3 of 13 Pages - -------------------------------------------------------------------------------- 1. Names of Reporting Persons Timothy F. Howe S.S. or I.R.S. Identification Nos. of Above Persons - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization U.S. Citizen - -------------------------------------------------------------------------------- 5. Sole Voting Power 0 Number of ----------------------------------------------------- Shares Beneficially 6. Shared Voting Power 410,000 Owned by ----------------------------------------------------- Each Reporting 7. Sole Dispositive Power 0 Person ----------------------------------------------------- With 8. Shared Dispositive Power 410,000 - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 410,000 - -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row 9 Excludes Certain Shares [ ] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row 9 4.0% - -------------------------------------------------------------------------------- 12. Type of Reporting Person IN - -------------------------------------------------------------------------------- CUSIP No. 45337C 10 2 13G Page 4 of 13 Pages - -------------------------------------------------------------------------------- 1. Names of Reporting Persons Schroder Ventures Limited Partnership S.S. or I.R.S. Identification Nos. of Above Persons - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power 247,123 Number of ----------------------------------------------------- Shares Beneficially 6. Shared Voting Power -0- Owned by ----------------------------------------------------- Each Reporting 7. Sole Dispositive Power 247,123 Person ----------------------------------------------------- With 8. Shared Dispositive Power -0- - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 247,123 - -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row 9 Excludes Certain Shares [ ] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row 9 2.4% - -------------------------------------------------------------------------------- 12. Type of Reporting Person PN - -------------------------------------------------------------------------------- CUSIP No. 45337C 10 2 13G Page 5 of 13 Pages - -------------------------------------------------------------------------------- 1. Names of Reporting Persons Schroders Incorporated S.S. or I.R.S. Identification Nos. of Above Persons - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power 100,000 Number of ----------------------------------------------------- Shares Beneficially 6. Shared Voting Power -0- Owned by ----------------------------------------------------- Each Reporting 7. Sole Dispositive Power 100,000 Person ----------------------------------------------------- With 8. Shared Dispositive Power -0- - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 100,000 - -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row 9 Excludes Certain Shares [ ] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row 9 1.0% - -------------------------------------------------------------------------------- 12. Type of Reporting Person CO - -------------------------------------------------------------------------------- CUSIP No. 45337C 10 2 13G Page 6 of 13 Pages - -------------------------------------------------------------------------------- 1. Names of Reporting Persons Schroder Ventures U.S. Trust S.S. or I.R.S. Identification Nos. of Above Persons - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Bermuda - -------------------------------------------------------------------------------- 5. Sole Voting Power 62,877 Number of ----------------------------------------------------- Shares Beneficially 6. Shared Voting Power -0- Owned by ----------------------------------------------------- Each Reporting 7. Sole Dispositive Power 62,877 Person ----------------------------------------------------- With 8. Shared Dispositive Power -0- - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 62,877 - -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row 9 Excludes Certain Shares [ ] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row 9 0.6% - -------------------------------------------------------------------------------- 12. Type of Reporting Person OO - -------------------------------------------------------------------------------- CUSIP No. 45337C 10 2 13G Page 7 of 13 Pages - -------------------------------------------------------------------------------- 1. Names of Reporting Persons Collinson Howe Venture Partners, Inc. (formerly known as Schroder Ventures Advisers, Incorporated) S.S. or I.R.S. Identification Nos. of Above Persons - -------------------------------------------------------------------------------- 2. Check the Appropriate Box if a Member of a Group (a) [X] (b) [ ] - -------------------------------------------------------------------------------- 3. SEC Use Only - -------------------------------------------------------------------------------- 4. Citizenship or Place of Organization Delaware - -------------------------------------------------------------------------------- 5. Sole Voting Power 100 Number of ----------------------------------------------------- Shares Beneficially 6. Shared Voting Power -0- Owned by ----------------------------------------------------- Each Reporting 7. Sole Dispositive Power 100 Person ----------------------------------------------------- With 8. Shared Dispositive Power -0- - -------------------------------------------------------------------------------- 9. Aggregate Amount Beneficially Owned by Each Reporting Person 100 - -------------------------------------------------------------------------------- 10. Check if the Aggregate Amount in Row 9 Excludes Certain Shares [ ] - -------------------------------------------------------------------------------- 11. Percent of Class Represented by Amount in Row 9 0% - -------------------------------------------------------------------------------- 12. Type of Reporting Person CO - -------------------------------------------------------------------------------- CUSIP No. 45337C 10 2 13G Page 8 of 13 Pages Item 1(a) Name of Issuer: Incyte Pharmaceuticals, Inc. Item 1(b) Address of Issuer's Principal Executive Offices: 3330 Hillview Avenue, Palo Alto, CA 94304 Item 2(a) Name of Person Filing: Jeffrey J. Collinson, Timothy F. Howe, Schroder Ventures Limited Partnership, Schroders Incorporated, Schroder Ventures U.S. Trust, and Collinson Howe Venture Partners, Inc. Item 2(b) Address of Principal Business Office or, if None, ------------------------------------------------- Residence: The address of the principal business --------- office of each of the filing entities and Mr. Collinson and Mr. Howe is Collinson Howe Venture Partners, Inc., 1055 Washington Boulevard, Stamford, CT 06901. Item 2(c) Citizenship: Schroder Ventures Limited ----------- Partnership is a limited partnership organized under the laws of the State of Delaware. Mr. Collinson and Mr. Howe are United States citizens. Schroder Ventures U.S. Trust is a Bermuda trust. Schroders Incorporated and Collinson Howe Venture Partners, Inc. are Delaware corporations. Item 2(d) Title of Class of Securities Common Stock, ---------------------------- $.001 par value ("Common Stock") Item 2(e) CUSIP Number: 45337C 10 2 ------------ Item 3. If this statement is filed pursuant to Rule 13d-1(b) or ------------------------------------------------------- 13d-2(b), check whether the person filing is a: ---------------------------------------------- (a) [ ] Broker or Dealer registered under section 15 of the Act (b) [ ] Bank as defined in section 3(a)(6) of the Act (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act (d) [ ] Investment Company registered under section 8 of the Investment Company Act (e) [ ] Investment Adviser registered under section 203 of the Investment Advisers Act of 1940 CUSIP No. 45337C 10 2 13G Page 9 of 13 Pages (f) [ ] Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund (g) [ ] Parent Holding Company, in accordance with section 240.13d-1(b)(ii)(G) (h) [ ] Group, in accordance with section 240.13d-1(b)(1)(ii)(H) Not Applicable. Item 4. Ownership. --------- Not Applicable. Item 5. Ownership of Five Percent or Less of a Class. -------------------------------------------- If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [X] Item 6. Ownership of More than Five Percent on Behalf of ------------------------------------------------ Another Person. -------------- Not Applicable. Item 7. Identification and Classification of the ---------------------------------------- Subsidiary Which Acquired the Security Being -------------------------------------------- Reported on by the Parent Holding Company. ----------------------------------------- Not Applicable. Item 8. Identification and Classification of Members of ----------------------------------------------- the Group. --------- Group is filing pursuant to 13d-1(c). An exhibit containing the identities of each member of the group is attached hereto as Exhibit I. Item 9. Notice of Dissolution of Group. ------------------------------ Not Applicable. CUSIP No. 45337C 10 2 13G Page 10 of 13 Pages Item 10. Certification. ------------- Not Applicable. This statement on Schedule 13G is not being filed pursuant to Rule 13d-1(b). CUSIP No. 45337C 10 2 13G Page 11 of 13 Pages Exhibit Index Exhibit Number Page Number I 13 CUSIP No. 45337C 10 2 13G Page 12 of 13 Pages Signature --------- After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Dated: February 10, 1997. SCHRODER VENTURES LIMITED PARTNERSHIP By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson Attorney-in-Fact SCHRODER VENTURES U.S. TRUST By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson Attorney-in-Fact SCHRODERS, INCORPORATED By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson Attorney-in-Fact COLLINSON HOWE VENTURE PARTNERS, INC. By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson President and Sole Shareholder JEFFREY J. COLLINSON By /s/ JEFFREY J. COLLINSON ------------------------------------- TIMOTHY F. HOWE By /s/ TIMOTHY F. HOWE ------------------------------------- CUSIP No. 45337C 10 2 13G Page 13 of 13 Pages EXHIBIT I --------- AGREEMENT --------- Pursuant to Rule 13d-1(f)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required on Schedule 13G need be filed with respect to ownership by each of the undersigned of shares of Common Stock of Incyte Pharmaceuticals, Inc. This Agreement may be executed in any number of counterparts, each of which shall be deemed an original. Dated: February 10, 1997. SCHRODER VENTURES LIMITED PARTNERSHIP By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson Attorney-in-Fact SCHRODER VENTURES U.S. TRUST By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson Attorney-in-Fact SCHRODERS, INCORPORATED By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson Attorney-in-Fact COLLINSON HOWE VENTURE PARTNERS, INC. By /s/ JEFFREY J. COLLINSON ------------------------------------- Jeffrey J. Collinson President and Sole Shareholder JEFFREY J. COLLINSON By /s/ JEFFREY J. COLLINSON ------------------------------------- TIMOTHY F. HOWE By /s/ TIMOTHY F. HOWE -------------------------------------